Abstract

Formulation and Stability of Solutions

Author(s): Akers Michael J

Issue: Mar/Apr 2016 - Volume 20, Number 2

Page(s): 137-141

Download in electronic PDF format for $75
  • Formulation and Stability of Solutions Page 1
  • Formulation and Stability of Solutions Page 2
  • Formulation and Stability of Solutions Page 3
  • Formulation and Stability of Solutions Page 4
  • Formulation and Stability of Solutions Page 5

Abstract

Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs formulated as solution almost always have chemical and physical stability challenges as well as solubility limitations and the need to prevent inadvertent microbial contamination issues. The first in this series of articles took us through a discussion of optimizing the physical stability of solutions. This article concludes this series of articles with a discussion on foreign particles, protein aggregation, and immunogenicity; optimizing microbiological activity; and osmolality (tonicity) agents, and discusses how these challenges and issues are addressed.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2016
Pg. 137-141
Author(s): Akers Michael J
May/Jun 2017
Pg. 223-228
Author(s): Akers Michael J
Jan/Feb 2016
Pg. 41-45
Author(s): Akers Michael J
Nov/Dec 2007
Pg. 476-481
May/Jun 2018
Pg. 240-246
Nov/Dec 2021
Pg. 523-527
Sep/Oct 2020
Pg. 388-395
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 336-341
Mar/Apr 2004
Pg. 147-152
May/Jun 2004
Pg. 228-230
Nov/Dec 2020
Pg. 473-478
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 242-245
Author(s): Ngim Kenley, Patel Jalpa
Jul/Aug 2017
Pg. 301-308
Author(s): Akers Michael J
Jan/Feb 2004
Pg. 46-48
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 322-329
Jan/Feb 2021
Pg. 73-81
Mar/Apr 2006
Pg. 156-158
Jan/Feb 2002
Pg. 66-69
Jan/Feb 2002
Pg. 70-73